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Abstract
Gene expression data, in conjunction with information on genetic variants, have enabled studies to identify expression
quantitative trait loci (eQTLs) or polymorphic locations in the genome that are associated with expression levels. Moreover,
recent technological developments and cost decreases have further enabled studies to collect expression data in multiple
tissues. One advantage of multiple tissue datasets is that studies can combine results from different tissues to identify eQTLs
more accurately than examining each tissue separately. The idea of aggregating results of multiple tissues is closely related
to the idea of meta-analysis which aggregates results of multiple genome-wide association studies to improve the power to
detect associations. In principle, meta-analysis methods can be used to combine results from multiple tissues. However,
eQTLs may have effects in only a single tissue, in all tissues, or in a subset of tissues with possibly different effect sizes. This
heterogeneity in terms of effects across multiple tissues presents a key challenge to detect eQTLs. In this paper, we develop
a framework that leverages two popular meta-analysis methods that address effect size heterogeneity to detect eQTLs
across multiple tissues. We show by using simulations and multiple tissue data from mouse that our approach detects many
eQTLs undetected by traditional eQTL methods. Additionally, our method provides an interpretation framework that
accurately predicts whether an eQTL has an effect in a particular tissue.
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Introduction
Advances in genotyping and gene expression technologies have
enabled researchers to study associations between genetic variants
and gene expression levels. These studies often treat expression
levels as quantitative traits and apply statistical tests to identify
genomic locations known as expression Quantitative Trait Loci
(eQTLs) that segregate the traits. Genome-wide maps of eQTLs
for several organisms including budding yeast [1,2], Arabidopsis
[3], mouse [4,5] and human [6,7] have been successfully
generated. Furthermore, recent technological developments and
cost decreases in microarrays allow studies to collect expression
data in more than one tissue in human [6,8,9] and mouse [4,5]. A
collection of expression data from multiple tissues enables studies
to explore the tissue-specific nature of eQTLs as well as their
global effects on different types of tissues.
Multiple tissue datasets can potentially allow studies to more
effectively identify eQTLs by combining information from
multiple tissues. Due to a limited sample size, a standard single
tissue eQTL method or ‘‘tissue-by-tissue’’ approach that examines
each tissue individually may not detect an eQTL in any one tissue,
or it may overestimate the proportion of tissue specific eQTLs
[10]. However, if a genetic variant is associated with the
expression of a gene in more than one tissue, we can aggregate
information from multiple tissues to increase statistical power. This
idea is similar to the idea of meta-analysis in genome-wide
association studies (GWAS) that combines results of several studies
on the same phenotype. In our case, each tissue is considered as a
separate ‘‘study’’ in the meta-analysis.
One key difficulty in combining results from multiple tissues is
that it is not known in which tissues a genetic variant has an effect.
For example, a variant may influence gene expression in all tissues,
may have different effects on different tissues, or may have an
effect in some tissues but may not have any effect in other tissues.
This phenomenon, different effect sizes among tissues, is called
heterogeneity. Meta-analysis methods have different assumptions
on the distribution of effect sizes, and to better detect eQTLs,
studies will perform best if they apply a meta-analysis method
whose assumptions are consistent with the actual effect sizes of
eQTLs in multiple tissues. For instance, if an eQTL has an effect
in all tissues, studies would perform best if they utilize the fixed-
effects model (FE) [11–13] that assumes no heterogeneity. On the
other hand, to effectively detect an eQTL whose effects on gene
expression differ across tissues, studies will perform best if they
apply the random-effects model (RE) [14–18] that considers
heterogeneity.
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Another challenge in applying meta-analysis to multi-tissue
datasets is that studies often collect multiple tissues from the same
individuals, which may cause the expression between tissues of the
same individual to be correlated. This correlation may cause false
positives for standard meta-analysis methods which assume a
disjoint set of individuals in each study.
In this paper, we present a novel approach called ‘‘Meta-
Tissue’’ that identifies eQTLs from multiple tissues by utilizing
meta-analysis. The critical advance of our methodology is that we
extend meta-analysis to a mixed model framework. We apply the
mixed model to account for the correlation of expression between
tissues, and perform meta-analysis to combine results from
multiple tissues. Since we do not know in advance the distribution
of effect sizes for eQTLs among different tissues, we utilize both
the FE and RE models to identify as many eQTLs as possible, and
for RE, we use a recently developed random-effects model [18]
that achieves higher statistical power than the traditional random-
effects model. We first show by simulations that Meta-Tissue is
more powerful than the tissue-by-tissue approach in detecting
eQTLs when eQTLs have effects in multiple tissues, while
controlling for the false positive rate correctly.
We then apply Meta-Tissue to a mouse expression dataset. This
dataset is ideal for evaluating methods for discovering eQTLs for
several reasons. The data are generated through a cross which
limits the genetic diversity in the dataset, and all variants have
similar frequencies which eliminate effects of allele frequency on
power. In addition, the dataset contains gene expression from
many different tissues and different numbers of individuals for the
tissues, allowing us to compare results between different scenarios.
We analyze four tissues from 50 samples per each tissue and ten
tissues from 22 samples. We apply Meta-Tissue to both datasets
and demonstrate that Meta-Tissue detects many eQTLs that are
undetected by the tissue-by-tissue method.
In addition to accurately detecting eQTLs from multiple tissues,
our method can also predict whether an eQTL affects or does not
affect expression in a specific tissue. Predicting the existence or
absence of an effect is a very difficult problem in meta-analysis,
and it is known that making predictions based on p-values is not
effective [19]. One of the reasons is that a non-significant p-value
is not necessarily evidence of an absence of an effect since the
study may be underpowered. Our method instead computes the
posterior probability of the presence or absence of an effect for
each study building on recent work in interpretation of meta-
analysis [19]. Applying the framework to the four and ten tissue
datasets, we identify more eQTLs that are predicted to have effects
in all tissues compared to the p-value based approach, which are
interesting potential candidates with possible global regulatory
mechanisms. Meta-Tissue is publicly available at http://genetics.
cs.ucla.edu/metatissue/.
Results
Meta-Tissue
The main idea of Meta-Tissue is that it combines the effect size
estimates from multiple tissues using a ‘‘meta-analysis’’ approach.
Meta-analysis techniques are widely applied to combine the results
of GWAS studies. In our case, we consider each tissues as a
‘‘study.’’ This has the advantage of increasing the statistical power
to detect eQTLs shared across tissues. There are several challenges
corresponding to the inherent differences between combining
GWAS studies and expression quantitative trait loci studies in
multiple tissues. The first challenge is that we expect that there
may be differences in effect sizes between tissues. For this reason,
we utilize both the random-effects model which allows Meta-
Tissue to detect eQTLs when heterogeneity is present, and the
fixed-effects model when it is not. A second challenge is that in
many multi-tissue eQTL study designs, multiple tissues are
collected from the same individuals which induce correlation
between measurements of expression levels in different tissues.
However, meta-analysis methods assume that studies are inde-
pendent and may be susceptible to false positives. To overcome
this challenge, we utilize the linear mixed model to correct our
effect size estimates before performing the meta-analysis.
We assume that multi-tissue eQTL studies collect expression
values of G genes from N individuals in T tissues. However, those
N individuals are not necessarily the same for all T tissues; some
individuals may provide a subset of tissues. The studies also collect
genotype information of M SNPs from the individuals. To
determine eQTLs in a specific tissue, or pairs of SNP and gene
that are significantly correlated, eQTL studies often use the
following linear model.
y
g
t~1atzxjbtze,
where y
g
t is gene expression g of individuals in tissue t, xj is
information on SNP j, and 1 is a vector of ones. bt is the effect size
of SNP j on gene g in tissue t, and if it is not zero, we claim the
pair of SNP j and gene g as an eQTL. The Tissue-By-Tissue
(TBT) approach computes bt for every tissue (t[f1 . . .Tg), and
determines whether at least one bt is not zero.
To increase the statistical power to detect eQTLs, Meta-Tissue
utilizes meta-analysis that combines bt from T tissues. A naive
approach to apply meta-analysis to multi-tissue eQTL datasets is
directly using bt computed from the linear model for TBT. This
approach, however, violates the main assumption of meta-analysis
that bt is independent for T tissues. Because multiple tissues are
often collected from the same individuals, there exists correlation
between gene expression values across different tissues, and this
leads to correlated bt.
To apply meta-analysis to correlated bt, Meta-Tissue uses a
linear mixed model to explicitly capture correlation between bt:
Yg~1azXjbzuze,
where Yg and Xj contain gene expression and SNP information in
all T tissues, and Figure 1 shows how they are encoded using a
simple example. u is the random effect of a mixed model due to
Author Summary
The combination of gene expression and genetic variation
data has enabled the identification of genetic variants that
affect gene expression levels. It has been shown that some
variants influence gene expression in only one tissue while
others influence gene expression in multiple tissues.
However, an analysis of multiple tissue data using
traditional statistical methods typically fails to identify
those variants that affect multiple tissues because each
tissue is treated independently and due to low statistical
power, the effect in a given tissue may be missed. Building
on recent advances in statistical methods for meta-analysis
and mixed models, we present a novel method that
combines information from multiple tissues to identify
genetic variation that affects multiple tissues. We show
that our method detects more genetic variation that
influences multiple tissues than traditional statistical
methods both on simulated and real data.
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the fact that multiple tissues are collected from the same
individuals. u follows the multivariate normal distribution whose
covariance matrix (D matrix in Figure 1) represents sharing of
individuals in multiple tissues. Meta-Tissue applies the generalized
least squares to estimate b and its covariance or correlation
between bt. Meta-Tissue ‘‘un-correlates’’ bt using the covariance it
estimated and use the ‘‘un-correlated’’ bt for meta-analysis (see the
Materials and Methods section for more details).
There is a fundamental difference between Meta-Tissue and the
TBT approach. The statistical test in Meta-Tissue tests whether or
not a gene is involved in an eQTL in any of the tissues. In other
words, the null hypothesis of Meta-Tissue assumes that no effect is
present in any of the tissues for a specific gene. A rejection of this
null hypothesis is effectively predicting the presence of an effect in
at least one of the tissues. However, the tissue-by-tissue approach
tests whether or not an eQTL is present in each tissue. Hence, the
null hypothesis of TBT assumes that no effect is present in a
specific tissue. This means that Meta-Tissue performs one test per
gene and TBT performs one test per gene in each tissue. In our
comparisons of Meta-Tissue and TBT, we adjust the significant
thresholds so that the overall false positive rate of implicating any
tissue of a gene in an eQTL is constant for both methods.
Once we identify a significant association using Meta-Tissue,
this means that at least one of the tissues contains an eQTL. In
order to identify which subset of the tissues contain an eQTL, we
utilize a recently developed meta-analysis interpretation frame-
work which computes an m-value statistic for each tissue [19]. The
m-value estimates the posterior probability that an effect is present
in a study included in a meta-analysis. Utilizing the m-values, we
can predict tissues in which an effect is present.
Power comparison by simulation
We first simulate gene expression data to compare the power
between the traditional Tissue-By-Tissue approach (TBT), Meta-
Tissue FE, and Meta-Tissue RE. We create a dataset that has 100
individuals with one SNP and one gene expression level simulating
one eQTL. We set the minor allele frequency to 30%. We
simulate four tissues and consider four scenarios where a SNP has
the same effect in (1) a single tissue, (2) in two tissues, (3) in three
tissues, and (4) in all four tissues. The first three scenarios
correspond to eQTLs with heterogeneity while eQTLs have no
heterogeneity in the last scenario. We check I2 statistics [20] of
eQTLs that measure the magnitude of heterogeneity in each
scenario and verify that eQTLs have high levels of heterogeneity
in the first three scenarios, but very low levels in the last scenario
(Figure S1). We assume that each individual provides four tissues,
and hence this simulation corresponds to a repeated measures
design. We use the mixed model discussed in the Materials and
Methods section to generate the gene expression levels of
individuals while taking into account the repeated measures
design. We generate 1,000 datasets (each a potential eQTL) and
the power is estimated as a proportion of eQTLs detected at a
significance threshold of 5|10{8 for meta-analysis methods. We
choose this threshold because the number of tests we perform in
mouse datasets is on the order of one million (135 SNPs|10,588
genes). The significance threshold adjusted for one million tests as
in typical GWAS is 5|10{8. For TBT, we apply a significance
threshold of 1:25|10{8(5|10{8=4) such that the overall false
positive rate of TBT is the same as that for Meta-Tissue as
discussed in the previous section.
To apply the proposed methods to the simulations, we use the
following approach. For TBT, we perform a standard F-test using
a linear model to obtain a p-value for each pair of a SNP and a
gene expression level in each tissue (see Materials and Methods).
The tissue-by-tissue approach declares a SNP-gene expression pair
as an eQTL if the p-value for the association statistic is below the
threshold for any one of the tissues. For Meta-Tissue, we first
perform generalized least squares (GLS) to correct for the fact that
individuals are shared among tissues. Meta-Tissue then combines
information from multiple tissues to obtain either fixed effect or
random effect meta-analysis p-values as described in the Materials
and Methods section. A SNP-expression pair is considered as an
eQTL if its meta-analysis p-value is below the significance
threshold. As a separate simulation, we verify that both of our
Figure 1. A simple example showing how gene expression and SNP in multi-tissue eQTL studies are encoded in the mixed model of
Meta-Tissue. This example has five samples (S1, S2, S3, S4, and S5) in three tissues (T1, T2, and T3). The leftmost table shows which tissues are
collected from each sample; yij means gene expression of jth sample in ith tissue, and NA means the tissue is not collected. In this example, each
tissue has gene expression measured in three samples. Yg is a vector containing expression of samples in all tissues; there are a total of 9 gene
expression values. In the Xj matrix, xi denotes genotype of ith sample. The b matrix contains three intercepts (at) and three bt for the three tissues. u
is the random effect of the mixed model, and u*N (0,s2vD). D is 9|9 matrix whose entry at ith row and jth column is 1 if the ith and jth entries of
Yg are collected from the same individual, and 0 otherwise.
doi:10.1371/journal.pgen.1003491.g001
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implementations (Meta-Tissue FE and RE) control the false
positive rates (Text S1). This simulation also shows that utilizing
the mixed model is critical for controlling false positives when
expression levels from multiple tissues are collected from the same
individual.
Figure 2 shows that Meta-Tissue methods are more powerful
than TBT when effects exist in multiple tissues; Meta-Tissue RE is
the most powerful when an eQTL has effects in two or three
tissues, and Meta-Tissue FE outperforms TBT and Meta-Tissue
RE when the effects exist in all tissues. The TBT approach has
higher power than Meta-Tissue methods when the effects exist in a
single tissue. These results show that TBT is an ideal approach to
detect an eQTL that is specific to a certain tissue while Meta-
Tissue approaches are ideal for detecting an eQTL that has effects
in more than one tissue. As the number of tissues with effects
increases, the power of Meta-Tissue methods increases while that
of TBT decreases. These results suggest an integrated approach in
eQTL studies to apply TBT for detecting tissue-specific eQTLs
and Meta-Tissue methods for detecting eQTLs shared between
tissues.
Simulation of heterogeneity in multiple tissues using
mouse data
To verify the results of the previous power simulation in real
multiple tissue data, we simulate heterogeneity using a liver
tissue expression from mouse. This dataset contains 108
samples, 135 SNPs and 10,588 probe expression levels. We
detect 389 eQTLs in this single tissue dataset using the
standard linear model with a p-value threshold of 5|10{8,
which corresponds to the false discovery rate (FDR) of 0.017%
level. We consider these detected associations as the gold
standard for measuring accuracy of methods in this simulation.
We then split the 108 samples into three groups of 36 samples
to simulate three tissues, and this means that eQTLs have
effects in all three tissues. In our simulations, we expect to find
fewer eQTLs because each of our ‘‘tissues’’ only has 36
samples compared to the original 108 samples. We then
consider three scenarios similar to scenarios in the previous
power simulation; (1) eQTLs have effects only in the first tissue
by permuting expression of the second and third tissues, (2)
eQTLs have effects only in the first and second tissues by
permuting expression of the third tissue, and (3) eQTLs have
effects in all three tissues without any permutation. Permuting
the expression of a specific tissue removes effects of eQTLs
from the tissue, and hence allows simulation of heterogeneity.
We apply Meta-Tissue FE, Meta-Tissue RE, and TBT to this
multiple tissue dataset and measure how many eQTLs out of
the original 389 eQTLs each method can recover using the
same threshold (5|10{8=3 for TBT). Because the number of
eQTLs methods recover can change depending on how we
Figure 2. Power comparison between the tissue-by-tissue approach, Meta-Tissue fixed effects model (FE), and Meta-Tissue random
effects model (RE) using simulated data. X-axis indicates the number of tissues having effects out of four tissues, and Y-axis is the power.
doi:10.1371/journal.pgen.1003491.g002
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split the 108 samples, we perform ten iterations of the
experiment where we divide individuals differently in each
iteration, and average the results.
The result of this simulation shows that Meta-Tissue methods
recover the most eQTLs when eQTLs have effects in more than
one tissue (Figure 3). When effects exist in two out of three tissues,
Meta-Tissue RE recovers the most eQTLs; it recovers 144 eQTLs
out of the 389 eQTLs on average, and this is 27% and 133% more
than the number of eQTLs Meta-Tissue FE and TBT recover,
respectively. When eQTLs have effects in all tissues, Meta-Tissue
FE recovers the most eQTLs, and when effects exist in a single
tissue, TBT does. This result is consistent with the previous power
simulation in which Meta-Tissue methods were more powerful
than TBT when eQTLs have effects in multiple tissues.
Detecting eQTLs in multiple tissue mouse data
We apply Meta-Tissue to detect eQTLs in multiple tissues from
mouse. Our data consists of two sets; one with four tissues (cortex,
heart, liver, spleen), and the other with ten tissues (bone marrow,
hippocampus, kidney, pancreas, stomach, white fat, and the four
tissues). The four tissue dataset has 50 samples per each tissue
while the ten tissue dataset has 22 samples per tissue. In both
datasets, not all individuals provided all different types of tissues;
on average, 34% of individuals are shared between two tissues in
the four tissue dataset while 11% of individuals are shared in the
ten tissues dataset. The number of SNPs (135 SNPs) and the
number of probes (10,588) are the same as those of the liver tissue.
Figures 4A (four tissues) and 4B (ten tissues) show the number of
eQTLs detected by Meta-Tissue RE, Meta-Tissue FE, and TBT
using a threshold of 5|10{8 (5|10{8/the number of tissues for
TBT). The number substantially increases by using Meta-Tissue
RE or FE, showing up to two fold and twelve fold increases
compared to TBT in the four and ten tissue datasets, respectively.
These results indicate that methods that combine results of
multiple tissues outperform a method that uses results of each
tissue separately as all meta-analysis methods detect more eQTLs
than TBT. Moreover, these results suggest a possibility that there
exist a considerable number of eQTLs with different effect sizes
across tissues as Meta-Tissue RE consistently identifies more
eQTLs than Meta-Tissue FE. In addition to the number of eQTLs
(SNP-expression pairs), we also analyze the number of eSNPs
(unique SNPs influencing gene expression) and eProbes (unique
probes for gene expression). Similar to the results of the number of
eQTLs, Meta-Tissue detects more eSNPs and eProbes than TBT
(Figure 5).
Another important implication comes from comparing the two
datasets. TBT finds substantially fewer number of eQTLs in the
ten tissue dataset than in the four tissue dataset. This is possibly
Figure 3. The average number of eQTLs that the tissue-by-tissue approach, Meta-Tissue FE, and Meta-Tissue RE recover from three
tissues generated from the liver tissue. The liver tissue has 108 samples from which we simulate three tissues of 36 samples. X-axis indicates the
number of tissues having effects out of three tissues. The original liver tissue has 389 eQTLs.
doi:10.1371/journal.pgen.1003491.g003
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because the sample size of each tissue is decreased from 50 to 22.
On the other hands, the meta-analytic methods find more eQTLs.
One possible reason is that the total sample size is slightly
increased from 200 to 220. Therefore, the results demonstrate that
by using information from multiple tissues and leveraging meta-
analysis methods, we may be able to detect eQTLs even if the
sample size for each tissue is small.
In addition to the number of eQTLs that different methods
detect, we also analyze the overlap of eQTLs using Venn diagrams
(Figures 4C and 4D). The Venn diagrams show the number of
eQTLs detected only by each of the three methods, by both TBT
and each of Meta-Tissue methods, by both Meta-Tissue methods,
and by all three methods. In the four tissue dataset, the three
methods detect 493 unique eQTLs overall, and a majority of
eQTLs (95.1% of total eQTL) are detected by either of Meta-
Tissue methods. There are, however, 24 eQTLs (4.9% of total
eQTLs) that only TBT detects, and they are likely to be tissue-
specific eQTLs. In the ten tissue dataset, almost all eQTLs (99.3%
Figure 4. The number of eQTLs detected by the tissue-by-tissue approach (TBT), Meta-Tissue FE, and Meta-Tissue RE in A) four and
B) ten tissues of mouse, and the overlap of eQTLs detected by the three methods in C) four and D) ten tissues. The datasets consist of
the gene expression levels from 50 individuals (four tissues) and 22 individuals (ten tissues). We apply a p-value threshold of 5|10{8 for Meta-Tissue
and a threshold of 5|10{8/the number of tissues for tissue-by-tissue. The Venn diagrams (C and D) show the number of eQTLs detected by either
TBT, FE, or RE, by TBT and either of FE and RE, by FE and RE, and by all three methods.
doi:10.1371/journal.pgen.1003491.g004
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of total eQTLs) are detected by Meta-Tissue RE or FE, and there
are 4 eQTLs (0.7% of total eQTLs) detected only by TBT, which
may be due to the low statistical power due to the limited number
of samples.
Instead of the common genome-wide significance threshold (e.g.
5|10{8) to identify eQTLs, an alternative approach is to use the
false discovery rate (FDR) approach, and we use the QVALUE
package in R [21] to compute a q-value for each SNP-expression
pair. We consider only cis-eQTLs for the FDR approach; we
consider an eQTL as cis if a SNP is on the same chromosome as
the probe for gene expression. While typical eQTL studies
consider 1 Mb as a distance between a SNP and a probe for cis-
eQTLs, we consider a much longer distance due to a small
number of genotyped SNPs (135 SNPs). Figures S2A and S2B
show the number of eQTLs detected by Meta-Tissue methods and
TBT using FDR of 0.05 level in four and ten tissues, respectively,
and Figures S2C and S2D are Venn digrams showing the overlap
of eQTLs. The results using the FDR approach are consistent with
those using the common genome-wide significance threshold;
Meta-Tissue RE detects most eQTLs among the three methods,
and a majority of eQTLs (86% and 93% of total eQTLs for four
and ten tissues) are detected either by Meta-Tissue RE or FE.
Measuring heterogeneity in mouse data
The number of eQTLs detected only by TBT or by RE in
Figures 4 and S2 indicates that there can be several eQTLs with
different effect sizes in different tissues. To measure the magnitude
of heterogeneity of eQTLs, we use the Cochran’s Q statistic [14]
and the I2 statistic [20]. We make a plot whose x-axis is the I2
statistic and whose y-axis is the log of p-value of Cochran’s Q
statistic, and a histogram showing the distribution of I2 statistics.
Figures S3, S4, and S5 show the heterogeneity of eQTLs detected
by TBT, FE, and RE, respectively, in the four tissues of mouse
data. These plots show that the eQTLs detected by RE show
higher level of heterogeneity than the eQTLs detected by FE, as
expected. Given the p-value threshold of 0:05=k where k is the
number of eQTLs detected, 65, 17, and 53 eQTLs show
statistically significant heterogeneity in TBT, Meta-Tissue FE,
and Meta-Tissue RE, respectively, using the p-value of Cochran’s
Q statistic.
Predicting the presence of effects in multiple tissue data
Our Meta-Tissue approach not only detects more eQTLs from
multiple tissues but also provides an interpretation framework that
predicts whether an eQTL has effects in a specific tissue. Meta-
Tissue computes a statistic called m-value [19], and it is the
posterior probability that an effect exists in a specific tissue. If the
m-value is greater than a threshold t, we predict that an effect
exists, and if it is less than 1{t, we predict that an effect does not
exist. Another approach to predict an effect is to use a p-value. In
this approach, an effect exists if a p-value is less than a significance
threshold and does not exist otherwise.
We first apply this prediction framework to the 3-way split liver
tissue dataset that we previously generated. Recall that the liver
tissue has 389 eQTLs, and we simulated three tissues from it and
three scenarios in which we varied heterogeneity of eQTLs. For
this simulation, we consider only the scenario where eQTLs have
effects in the first two tissues out of three since this corresponds to
heterogeneity in which the number of eQTLs that TBT and Meta-
Tissue recover is relatively large. We measure how accurately
Meta-Tissue and the p-value approach predict the presence and
absence of effects of the 389 eQTLs in the three tissues. More
specifically, Meta-Tissue makes a correct prediction if m-values
are greater than 0.9 in the first two tissues and the m-value is less
than 0.1 in the third tissue (t~0:9). We consider an m-value
prediction to be ambiguous if any of the three tissues has the m-
value between 0.1 and 0.9. If the prediction is not either correct or
ambiguous, it is considered as an incorrect prediction. For the p-
value approach, p-values of the first two tissues need to be less than
the significance threshold (5|10{8/3) and p-value of the third
Figure 5. The number of eSNPs and eProbes detected by the tissue-by-tissue (TBT) approach, Meta-Tissue FE, and Meta-Tissue RE
in A) four tissues and B) ten tissues of mouse. We apply a p-value threshold of 5|10{8 for Meta-Tissue and a threshold of 5|10{8/the
number of tissues for TBT.
doi:10.1371/journal.pgen.1003491.g005
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tissue needs to be greater than the threshold for a correct
prediction. Otherwise, the prediction is an incorrect prediction
since the p-value approach does not have the notion of the
ambiguous prediction. In the original 3-way split liver tissue
experiment, we had ten simulations which differed in how the
individuals were divided. Over the ten simulations, Meta-Tissue
and TBT recovered 146 eQTLs out of total 389 eQTLs on
average (Figure 3). Since we use m-values for the interpretation
purpose (not for detecting eQTLs), we apply m-values to only
those 146 eQTLs. We also predict effects of the 146 eQTLs using
the p-value approach.
Meta-Tissue makes the correct prediction for 35% (51/146) of
the eQTLs and predicts the ambiguous prediction for 56% (82/
146). The p-value approach only makes the correct prediction for
11% (16/146) of the eQTLs. The number of correct predictions of
Meta-Tissue is more than three times greater. In addition, given the
advantage of the fact that Meta-Tissue can make ambiguous
predictions, the number of incorrect predictions for Meta-Tissue
(13/146) is ten times fewer than that for the p-value approach (130/
146). The results demonstrate that by combining the meta-analysis
method and the interpretation framework, we may predict effects of
eQTLs more accurately than the approach utilizing p-values.
We then apply our interpretation framework to the four and ten
multiple tissue datasets from mouse to predict effects of eQTLs
that were discovered using Meta-Tissue and TBT (493 and 568
eQTLs in four and ten tissue datasets, respectively). We calculate
the m-value for each eQTL per each tissue and make a prediction
that the eQTL affects expression in that tissue if the m-value is
greater than 0.9. We also compare our approach to the p-value
approach as in the previous simulation using the same threshold
(5|10{8/the number of tissues).
First, we apply the two approaches to the four tissue dataset,
and Table 1 lists the number of eQTLs predicted to have effects
across various combinations of tissues (e.g. eQTLs affecting
expression in heart/liver, heart/cortex, heart/liver/cortex). The
results show that Meta-Tissue consistently categorizes more
eQTLs having effects in multiple tissues than the p-value
approach. Among those eQTLs, ones that influence expression
levels in all tissues are particularly interesting because they may
provide insights into the global regulatory mechanisms of eQTLs.
Meta-Tissue predicts 283 such eQTLs while the p-value approach
predicts 15 eQTLs. The small number of predictions in p-value
approach is expected because even if the effect exists in all T
tissues, given power p of tissue-by-tissue approach, we can predict
the global effect only with probability pT .
We next predict effects of eQTLs in the ten tissue dataset, and
for this dataset, we would expect to detect a fewer number of
eQTLs having effects across all tissues since it becomes less likely
that all p-values or m-values pass the threshold as we try to detect
effects in more tissues. Table 2 shows the number of eQTLs
predicted to affect expression across different numbers of tissues
considered (e.g. eQTLs having effects across any two tissues, any
three tissues). Similar to the results of the four tissue dataset, Meta-
Tissue predicts more eQTLs with effects in several tissues than the
p-value approach. Unlike the four tissues, we detect a fewer
number of eQTLs having effects in all ten tissues; 134 and zero
such eQTLs by Meta-Tissue and the p-value approach, respec-
tively. The results indicate the intrinsic difficulty in detecting
eQTLs influencing expression across many different tissues.
Discussion
We presented a statistically powerful approach to detect eQTLs
from multiple tissues. Our approach, Meta-Tissue, takes advan-
tage of two meta-analysis methods that differ in their assumptions
on effects of eQTLs in different tissues. The first method assumes
that effects exist in all tissues with the same magnitude, and this
assumption allows us to detect eQTLs shared across all tissues.
The second method assumes that effect sizes of variants are
different among studies. By assuming the heterogeneity, we may
be able to accurately describe the nature of eQTLs whose patterns
of genetic regulation differ across tissues. Meta-analysis methods,
however, assume that studies are independent, and this assump-
tion is unlikely to be true in multi-tissue dataset since studies collect
multiple tissues from the same individuals. This may cause
correlation in expression between tissues, and to correct for the
correlation, we utilized a mixed model that enables the meta-
analysis method to achieve correct false positive rates.
To measure the performance of Meta-Tissue, we first showed
by simulations that our methods are generally more powerful than
a naive approach that looks at results of each tissue individually.
Table 1. The number of eQTLs predicted to have effects by
Meta-Tissue and the p-value approach across various
combinations of the four tissues.
Tissues Meta-Tissue p-values
Cortex/Heart 7 6
Cortex/Liver 1 2
Cortex/Spleen 4 2
Heart/Liver 7 3
Heart/Spleen 7 4
Liver/Spleen 10 2
Cortex/Heart/Liver 28 7
Cortex/Heart/Spleen 49 1
Cortex/Liver/Spleen 17 0
Heart/Liver/Spleen 24 2
All four tissues 283 15
Meta-Tissue uses m-value statistics to predict effects; if m-value is greater than
0.9, the effect exists. The p-value approach uses p-values to make predictions;
the effect exists if p-value is less than the significance threshold (5|10{8/the
number of tissues).
doi:10.1371/journal.pgen.1003491.t001
Table 2. The number of eQTLs predicted to have effects by
Meta-Tissue and the p-value approach across different
numbers of tissues considered in the ten tissue dataset (eQTLs
having effects across any two tissues, any three tissues, etc.).
Meta-Tissue p-values
2 tissues 12 10
3 tissues 7 0
4 tissues 20 4
5 tissues 33 0
6 tissues 36 1
7 tissues 88 0
8 tissues 99 0
9 tissues 124 0
10 tissues 134 0
doi:10.1371/journal.pgen.1003491.t002
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Next, by using data from mouse liver tissue, we simulated the
heterogeneity in effect sizes across a subset of tissues as well as in
all tissues. Meta-Tissue methods were shown to recover more
original eQTLs from multiple tissues than the naive tissue-by-
tissue approach when effects exist in multiple tissues. We then
observed that Meta-Tissue detects many eQTLs that the naive
approach does not detect in four and ten tissue datasets from
mouse. However, we note that there are a few tissue-specific
eQTLs that only the naive approach detects, and hence we
recommend that eQTL studies also apply the naive approach in
addition to Meta-Tissue.
In addition to detecting more eQTLs, Meta-Tissue can also
accurately predict whether an effect exists in a specific tissue.
Meta-Tissue calculates the posterior probability that an eQTL has
an effect in a certain tissue, and we demonstrated that this
probability is more effective in predicting the effect than a p-value
is by using the same liver tissue simulation. We then predicted
effects of eQTLs that we found in the four and ten tissue datasets
and showed our method predicts more eQTLs having effects in
multiple tissues than the p-value approach.
Our approach is fundamentally different from previous
approaches that also attempt to detect eQTLs from multiple
tissues, and to the best of our knowledge, Meta-Tissue is the first
method to apply both a mixed model and meta-analysis methods
to eQTL mapping. A traditional approach to detect associations
from repeated measurements from same individuals such as
multiple tissue data is MANOVA. However, MANOVA is not
directly applicable to our multiple tissue data because not all
samples provided all different types of tissues, and hence our data
are not completely ‘‘repeated measurements.’’ Meta-Tissue is
more general than MANOVA since Meta-Tissue can be applied
to both ‘‘repeated measures design’’ in which individuals are
shared across all tissues and to a scenario in which only a subset of
individuals are shared. Another advantage of our method is that
Meta-Tissue can take into account population structure by adding
an additional variance component term in our mixed model. This
may be important to multiple tissue datasets in which individuals
are sampled from different populations, which may cause inflation
of false positives.
Meta-Tissue leverages the recently developed random effects
model [18] that achieves higher power than the traditional
random effects model [14–17]. Han and Eskin showed that the
traditional random effects model never achieves higher power
than the fixed effects model due to its conservative null hypothesis.
We apply the traditional RE to our power simulation (Figure S6),
the heterogeneity experiment with the liver tissue (Figure S7), and
the four and ten tissue datasets of mouse data (Figure S8), and we
observe the same phenomenon; the traditional RE is always less
powerful than FE and the recently developed RE.
There are a few other methods that attempt to detect eQTLs
from the multiple tissue data such as Sparse Bayesian Multiple
Regression and the GFlasso approach proposed by Petretto et al.
[22] and Kim et al. [23] However, a key difference between these
methods and Meta-Tissue is that they attempt to detect multiple
variants (‘‘multi-locus’’) associated with multiple traits while our
method focuses on an association of a single variant. Another
difference and one main advantage of Meta-Tissue is that since it
is a meta-analysis method, studies can combine results of many
published eQTL analyses without actual data assuming that those
analyses are independent; only results of an eQTL analysis such as
effect size estimates are needed when the analyses are indepen-
dent. Meta-Tissue has another advantage that it is simpler and
more computationally efficient than other methods that involve
computationally challenging algorithms such as Bayesian variable
selection and regularized linear regression including Lasso. While
we applied Meta-Tissue to the multi-tissue dataset with a small
number of genotyped SNPs and samples (135 SNPs and about a
total of 200 samples across tissues), our algorithm and software are
efficient enough to be applied to larger eQTL studies where there
are hundreds of individuals genotyped at hundreds of thousands
SNPs.
Materials and Methods
Mouse strains
F1N2 mice from a C57BL6/N6129/OlaHsd cross were
produced as follows. Male ES cell chimeric founders (E14 ES
line [24]) were crossed to C57BL6/N females (Harlan Laborato-
ries). Male agouti offspring were backcrossed to C57BL6/N
females, and F1N1 offspring were intercrossed to produce F1N2
animals, Figure 6. All animals were maintained in ventilated
microisolator caging (Allentown), fed a standard lab chow diet
(Harlan Teklad) and provided water ad libidem. F1N2 animals
were group housed with littermates until 9 weeks of age. Mice
selected for tissue harvest were singly housed for one additional
week, to minimize socialization effects. Only males were used, to
avoid estrus related effects on gene expression. While the
production crosses segregated various gene targeted alleles, all
mice selected for this study carried only wild type genomes and did
not carry any engineered genomic alterations such as gene
knockouts.
Gene expression
Animals were sacrificed by cervical dislocation and immediately
dissected. A set of thirty tissues were collected from each animal in
a prescribed order, beginning with the pancreas. Each tissue was
briefly rinsed in PBS and deposited in RNAlater (Ambion), held at
room temperature to allow diffusion of RNAlater into the tissue,
and then stored at 286C.
Tissue homogenization, total RNA isolation, cDNA production,
in vitro transcription and fluorescent labeling were performed as
per Affymetrix gene chip recommended protocols. The hybrid-
ization mixes were analyzed using Affymetrix U74Av2 expression
microarrays, washed and scanned using Affymetrix instrumenta-
tion and protocols.
We consider the 10588 probes for which we have annotations.
For each tissue type, we filter out array outliers which show an
average correlation of v0:98 with respect to all other arrays.
The mice were genotyped at 140 SNPs that are polymorphic
between 129S1/SvImJ and C57BL/6J from the JAX SNP
Genotyping Panel [25]. Information on SNPs is listed in Table
S1. We use 135 out of the 140 SNPs that are polymorphic in all
tissues for our analysis.
Normalization and selection of individuals
In our analysis, we consider the gene expression levels of
G~10588 probes collected in 4 tissues (liver, spleen, cortex and
heart) over N~50 individuals. To be consistent with the different
tissue datasets we analyze, we randomly chose 50 individuals from
those datasets that have more than 50 individuals. We first used
RMA to perform background adjustment on the raw expressions
and then quantile normalization to normalize the adjusted
expressions. For 10 tissues, we collect the same number of gene
expression levels over N~22 individuals.
Power simulation framework
Our power simulation assumes that we collect four tissues from
100 individuals, and considers four scenarios where an eQTL has
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an effect in (1) one tissue, (2) in two tissues, (3) in three tissues, and
(4) in all four tissues. To generate the gene expression level of
individuals that considers the repeated measurements from the
same individuals, we first sample gene expression from the
multivariate normal distribution:
ye~e ð1Þ
where ye is a vector of size 400 corresponding to gene expression
of 100 individuals in 4 tissues, and e*N (0,s2vDzs2eI) where D is
a 400 by 400 matrix representing correlation between individuals
across the tissues. More specifically, Dij~1 if i and j are the same
individual between two tissues, and Dij~0 otherwise. I is an
identity matrix with size of 400. s2v and s
2
e are coefficients of the
two variance components, and we use the real mouse dataset to
obtain realistic values of the two coefficients. We estimate s2v and
s2e for every pair between a gene expression and a SNP, and find
that on average, s2v~0:0988 and s
2
e~0:9039. We use these values
for our simulation.
After sampling ye, we add a SNP effect to ye for tissues in which
an effect exists using the following equation:
yt~xbtzy
e
t
where yt is gene expression of 100 individuals in tissue t
(t[f1,2,3,4g), yet is ye on tissue t (size of 100), and x is SNP
information of 100 individuals. bt~0 if an eQTL does not have an
effect in tissue t, and btw0 if an eQTL has an effect. Since the
goal is to compare the relative power between methods, we vary
the effect size (bt) depending on the scenario to avoid too high or
too low power. Specifically, we set bt~1:5,1:175,1:0,0:75 for the
scenarios (1), (2), (3), (4), respectively.
Linear model for tissue-by-tissue approach
We assume an additive linear model to represent the
relationship between the expression of one gene and one SNP.
We can write that relationship in the following way for an
arbitrary gene g and SNP j at tissue t:
y
g
t~1atzxjbtze, ð2Þ
where y is a size N vector denoting gene expression levels of N
individuals, xj is a size N vector denoting SNP, 1 is a vector of
ones, and e*N(0,s2I). To assess the significance of an association
between a SNP and a gene, we perform a standard F-test for the
null hypothesis bt~0 and also obtain an estimate of bt using the
lm function in R. In the tissue-by-tissue approach, if any single
tissue turns out to be significant (bt=0), the pair of SNP and gene
expression are reported as a significant eQTL. TBT can also find
tissues in which an eQTL exists by examining which bt is non-
zero.
Figure 6. The mice were generated by creating a chimera with heterozygous 129/Sv cells in a C56Bl/6J blastocyst. The chimera was
crossed with a wildtype C56Bl/6J to obtain heterozygous KOs and homozygous WTs. The heterozygous KOs were backcrossed to wildtype C56Bl/6J
to obtain animals that are 75% C56Bl/6J. The male and female heterozygous KOs are intercrossed and only the resulting wildtype males are used in
this study. The complicated structure of the cross is due to the fact that the knockouts were designed to be used subsequently for other studies.
doi:10.1371/journal.pgen.1003491.g006
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Meta-Tissue - linear mixed model
We use a linear mixed model to take into account the fact that
eQTL studies collect multiple tissues from the same individuals.
This is called a ‘‘repeated measures design,’’ and the mixed model
is often used to model the correlation induced by the repeated
measurements such as in longitudinal data. Let T be the number
of tissues, and for simplicity, we assume there are N individuals for
each tissue, but individuals collected in one tissue do not
necessarily completely overlap with those in another tissue; it is
possible that some individuals may provide all tissues while others
may provide a subset. We also assume that we have SNP
information for all individuals. We apply the following linear
mixed model to assess the statistical significance between gene
expression g and SNP j:
Yg~1azXjbzuze, ð3Þ
Here is a description of each variable in above equation. Let
NT~N|T .
N Y is an NT|1 matrix denoting expression levels of N
individuals in T tissues. In other words, the first N rows are
expression of N individuals in the first tissue, the next N are
expression in the second tissue, and so on. Expression values of
each tissue are normalized to N (0,1).
N 1 is an NT|T matrix denoting the intercepts for T tissues.
The first column of 1 denotes the intercept for the first tissue;
the first N rows are ones, and the next NT{N are zeros. In
the second column that denotes the intercept for the second
tissue, the first N rows are zeros, the next N rows are ones, and
the next NT{2T rows are zeros.
N a is a T|1 matrix denoting coefficients of intercepts.
N Xj is an NT|T matrix denoting SNP for T tissues. This is
similar to the 1 matrix, and we replace ones in the 1 matrix
with SNP information. For example, in the first column, the
first N rows are SNP information of N individuals in the first
tissue, and the next NT{N rows are zeros.
N b is a T|1 matrix denoting coefficients of SNP effects in T
tissues.
N u is the random effect of the mixed model due to the repeated
measurements of individuals, and u*N (0,s2vD) where D is an
NT|NT matrix representing how individuals are shared
across the tissues (discussed in the Power simulation framework
section). e represents random errors and e*N (0,s2eI) where I
is an identity matrix. To efficiently estimate the two variance
components (s2v and s
2
e ), we use the efficient mixed-model
association (EMMA) package [26].
To estimate b and its covariance, we apply the generalized least
squares. Let S~s^2vDzs^
2
eI. Then, the estimated b is
b^~ X0jS
{1Xj
 {1
X0jS
{1Ym ð4Þ
Meta-Tissue - meta-analysis
Given the estimate b^~(b^1,:::,b^T ), we combine information
from multiple tissues by applying meta-analysis to b^. If the effect of
eQTL is the same for all tissues, applying fixed effects model (FE)
meta-analysis will be a powerful approach. If the effects of eQTL
differs by tissues, applying random effects model (RE) meta-
analysis will be a powerful approach [18].
Fixed effects model. Fixed effects model (FE) is a meta-
analysis method that assumes the effect size of a variant is fixed
across datasets [12,13], and its statistic is computed based on the
inverse-variance-weighted effect size [27]. Let B1, . . . ,BT and
V1, . . . ,VT be the estimates of effect-size and the standard error of
Bi, respectively, in T tissues. Let m be the unknown true effect size.
The null hypothesis of FE is m~0; in other words, effect size in all
tissues is zero. A statistic of FE (SFE ) and its distribution under the
null hypothesis are
SFE~
PT
i~1 V
{1
i BiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiPT
i~1 V
{1
i
q *N (0,1) ð5Þ
A p-value of SFE is obtained from the standard normal
distribution.
Random effects model. Our Meta-Tissue method leverages
new random effects model (RE) [18] to detect eQTLs from
multiple tissues while taking into account heterogeneity of effect
sizes in different tissues. The assumption of the random effects
model is that the effect size of a variant is different among datasets
and follows a probability distribution with mean m and variance t2.
The null hypothesis of the random effects model is equivalent to
that of the fixed effects model; that is, m~0. The traditional
random effects model, however, assumes a conservative null
hypothesis model. The new random effects model corrects this
conservative null hypothesis model and outperforms the tradition-
al random effects model. More specifically, a statistic of RE (SRE )
is defined as
SRE~
X
log
Vi
Vizt^2
 
z
XB2i
Vi
{
X Bi{m^ð Þ2
Vizt^2
ð6Þ
where m^ and t^2 are estimated mean and variance of the effect size,
and the maximum likelihood estimates of the two parameters are
calculated iteratively as following
m^(nz1)~
P
Vizt^
2
(n)
 {1
BiP
Vizt^
2
(n)
 {1 t^2(nz1)~
P Bi{m^(nz1) 2{Vi
Vizt^
2
(n)
 2
P
Vizt^
2
(n)
 {2
The initial value of t^2 is estimated using approaches in the
traditional random effects model [14,20,28]. We obtain a p-value
of SRE from p-value tables that are constructed from numerous
null statistics.
Accounting for covariance of effect size estimates. Since
we use linear mixed model to account for the fact that multi-tissue
eQTL studies often collect multiple tissues from the same
individuals, our estimates of effect size, b^~(b^1,:::,b^T ) in Equation
(4) can become correlated. The covariance structure is estimated
using the standard formula of the generalized least squares,
var(b^)~ X0jS
{1Xj
 {1
ð7Þ
It is important that the meta-analysis methods account for this
covariance structure of effect size estimates.
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To take into account the covariance structure in meta-analysis,
we use an extension [29] of the Lin and Sullivan approach [30].
Given b^ and their covariance V~var(b^), the optimal fixed effects
model meta-analysis statistic is
SLin~
eTV{1b^
eTV{1e
where e is the vector of ones (e~(1,:::,1)). The variance of the
statistic is given
var(SLin)~
1
eTV{1e
Note that if b^ is independent (V is a diagonal matrix), SLin and
var(SLin) are equivalent to the inverse-variance weighted effect
size estimate (the numerator of equation (5)) and its variance.
It can be shown that this approach is equivalent to building a
new ‘‘un-correlated’’ variance of b^,
varnew(b^)~Diag(V
{1e){1
and then giving b^ and varnew(b^) as input to the traditional meta-
analysis approaches assuming independent estimates [29]. This
‘‘un-correlating’’ idea allows us flexibility to use the correlated
estimates in any meta-analysis framework requiring independent
estimates. We use b^ and its ‘‘un-correlated’’ variance for the fixed
effects model (which gives equivalent results to the Lin and
Sullivan approach [30]), random effects model, heterogeneity
estimation (Q and I2), and the m-value estimation [19].
Predicting effects of eQTLs in multiple tissues. To
predict whether an eQTL has effects in a specific tissue, Meta-
Tissue computes a statistic called the ‘‘m-value’’ proposed by Han
and Eskin [19] that specifies the posterior probability that an effect
exists in a tissue. First, we denote B as a vector of Bi;
B~fB1,B2, . . . ,BTg. Let Ri be a random variable whose value
is 1 if dataset i has an effect and 0 otherwise. We also denote R as a
vector of Ri, and since each Ri has two values, R has 2
T possible
values. Let rj be one of those 2
T values, and let U~fr1, . . . ,r2T g
denote a vector of rj . To estimate the m-value mi, we need to
compute the probability, P(Ri~1DB), which is the probability of
dataset i having effects given the observed effect sizes. We can
compute this probability using the Bayes’ theorem
mi~P(Ri~1DB)~
P
r[Ui
P(BDR~r)P(R~r)P
r[U P(BDR~r)P(R~r)
where Ui is a set of rj in which ith value is 1. The equation shows
that we need to compute P(BDR~r) and P(R~r) terms for every r
to compute mi. We can compute P(R~r) as
P(R~r)~
Beta(DrDzc,T{DrDzd)
Beta(c,d)
where DrD denotes the number of 1’s in r and Beta denotes the beta
function. c and d are set to one [19]. The probability of B given r,
P(BDR~r), is computed as
P(BDR~r)~D:N(B; 0, Vzs2)P
i[q0
N(Bi; 0,Vi)
where
B~
P
i[q1
WiBiP
i[q1
Wi
and V~
1P
i[q1
Wi
N(B; a,b) denotes the probability density function of the normal
distribution with mean equal to a and variance equal to b, and q0
and q1 denote the indices of 0 and 1 in r, respectively.Wi~V
{1
i is
the inverse variance, and N(0,s2) is the prior for the effect size;
s~0:2 when an effect is small while s~0:4 when an effect is large
for binary traits [31,32]. For quantitative traits, there is no general
guidelines for the normally distributed priors, so we choose to use
the default value s~0:2. D is a scaling factor defined as
D~
1
(
ffiffiffiffiffi
2p
p
)T{1
ffiffiffiffiffiffiffiffiffiffiffiffiffi
Pi WiP
i Wi
s
:exp {
1
2
X
i
WiB
2
i{
(
P
i WiBi)
2P
i Wi
 !( )
More detailed derivations of P(BDR~r) and P(R~r) terms are
discussed in Han and Eskin [19].
Practical issues in combining mixed model and meta-
analysis
There are subtle issues in our framework combining mixed
model and meta-analysis. First, the effect size estimates from linear
model or mixed model are typically t-distributed, while most of
meta-analysis methods assume normally distributed effect sizes.
Second, our approach simultaneously considers all tissues using
Equation (3), but the error model is slightly different from the
tissue-by-tissue approach in Equation (2). In the tissue-by-tissue
approach, the error e*N(0,s2I) is fit in each tissue separately,
while in our new approach, the error is fit in all tissues together,
which is often less powerful than the former. We correct for these
subtle differences using simple heuristics (See Text S2).
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Supporting Information
Figure S1 Histograms showing the distribution of I2 statistics in
the power simulation. There are four scenarios in the power
simulation where an eQTL has an effect 1) in one tissue, 2) in two
tissues, 3) in three tissues, and 4) in all four tissues. There are 1,000
eQTLs in each scenario, and the histograms show the distribution
of I2 statistics of the 1,000 eQTLs.
(TIF)
Figure S2 The number of eQTLs detected by the tissue-by-
tissue approach (TBT), Meta-Tissue FE, and Meta-Tissue RE in
A) four and B) ten tissues of mouse using FDR of 5%, and the
overlap of eQTLs detected by the three methods in C) four and D)
ten tissues. We consider only cis-eQTLs for the FDR approach,
and a pair of SNP-probe for gene expression are considered cis if a
SNP and a probe are on the same chromosome.
(TIF)
Figure S3 A plot showing heterogeneity of eQTLs detected by
the tissue-by-tissue approach. X-axis of the top plot indicates I2
statistic and Y-axis indicates log of p-value of Cochrans Q statistic.
The vertical dashed line is drawn at I2 = 50%, and the horizontal
dash line is drawn at p-value = 0.05/the number of eQTLs
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detected. The bottom histogram shows the distribution of I2
statistic.
(TIF)
Figure S4 A plot showing heterogeneity of eQTLs detected by
Meta-Tissue FE. X-axis of the top plot indicates I2 statistic and Y-
axis indicates log of p-value of Cochrans Q statistic. The vertical
dashed line is drawn at I2= 50%, and the horizontal dash line is
drawn at p-value = 0.05/the number of eQTLs detected. The
bottom histogram shows the distribution of I2 statistic.
(TIF)
Figure S5 A plot showing heterogeneity of eQTLs detected by
Meta-Tissue RE. X-axis of the top plot indicates I2 statistic and Y-
axis indicates log of p-value of Cochrans Q statistic. The vertical
dashed line is drawn at I2= 50%, and the horizontal dash line is
drawn at p-value = 0.05/the number of eQTLs detected. The
bottom histogram shows the distribution of I2 statistic.
(TIF)
Figure S6 Power comparison between the tissue-by-tissue
approach, Meta-Tissue fixed effects model (FE), Meta-Tissue
random effects model (RE), and Meta-Tissue traditional random
effects model using simulated data. X-axis indicates the number of
tissues having effects out of four tissues, and Y-axis is the power.
(TIF)
Figure S7 The average number of eQTLs that the tissue-by-
tissue approach, Meta-Tissue FE, Meta-Tissue RE, and Meta-
Tissue traditional RE recover from three tissues generated from
the liver tissue. Effects of eQTLs exist in only two tissues. The
original liver tissue has 389 eQTLs.
(TIF)
Figure S8 The number of eQTLs detected by the tissue-by-
tissue approach, Meta-Tissue FE, Meta-Tissue RE, and Meta-
Tissue traditional RE in A) four tissues and in B) ten tissues of
mouse.
(TIF)
Table S1 Information on genotyped SNPs (chromosome, ID,
and position).
(XLS)
Text S1 False positive rates of Meta-Tissue.
(PDF)
Text S2 Practical issues in combining mixed model and meta-
analysis.
(PDF)
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